NEW YORK, NY / ACCESSWIRE / November 29, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

Uniti Group Inc. (NASDAQGS:UNIT)

UNIT Lawsuit on behalf of: investors who purchased April 20, 2015 – February 15, 2019
Lead Plaintiff Deadline : December 30, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/uniti-group-inc-loss-form?prid=4649&wire=1

According to the filed complaint, during the class period, Uniti Group Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Uniti's financial results were not sustainable because its customer Windstream had defaulted on its unsecured notes; and (ii) as a result of the foregoing, Defendants' statements about Uniti's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

Zendesk, Inc. (NYSE:ZEN)

ZEN Lawsuit on behalf of: investors who purchased February 6, 2019 – October 1, 2019
Lead Plaintiff Deadline : December 23, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/zendesk-inc-loss-form?prid=4649&wire=1

According to the filed complaint, during the class period, Zendesk, Inc. made materially false and/or misleading statements and/or failed to disclose that: (a) Zendesk's clients had been subject to data breaches dating back to 2016; (b) Zendesk was experiencing slowing demand for its Software as a Service offerings, particularly in Germany, the United Kingdom, and Australia, due in large part to political uncertainty and China trade issues there; and (c) as a result of the foregoing, Zendesk's business metrics and financial prospects were not as strong as defendants had led the market to believe during the Class Period.

UP Fintech Holding Limited (NASDAQ:TIGR)

TIGR Lawsuit on behalf of: investors who purchased all persons and entities that purchased or otherwise acquired: (a) Fintech American Depository Shares pursuant and/or traceable to the Company's initial public offering conducted on or about March 20, 2019; or (b) Fintech securities between March 20, 2019 and May 16, 2019.
Lead Plaintiff Deadline : January 6, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/up-fintech-holding-limited-loss-form?prid=4649&wire=1

According to the filed complaint, (i) Fintech was experiencing a material decrease in commissions because of a negative trend related to risk-averse investors in the market; (ii) Fintech was unable to absorb costs associated with the rapid growth of its business and its status as a publicly listed company on a U.S. exchange; (iii) Fintech was incurring significant additional expenses related to, inter alia, employee headcount and employee compensation and benefits; (iv) all of the foregoing had led to Fintech significantly increasing operating costs and expenses; and (v) as a result, the documents filed by the Company in connection with the initial public offering were materially false and/or misleading and failed to state information required to be stated therein, and the Company's Class Period statements were likewise materially false and/or misleading.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP 

ReleaseID: 568511

NEW YORK, NY / ACCESSWIRE / November 29, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

Capital One Financial Corporation (NYSE:COF)

COF Lawsuit on behalf of: investors who purchased February 2, 2018 – July 29, 2019
Lead Plaintiff Deadline: December 2, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/capital-one-financial-corporation-loss-form?prid=4648&wire=1

According to the filed complaint, during the class period, Capital One Financial Corporation made materially false and/or misleading statements and/or failed to disclose that: (1) the Company did not maintain robust information security protections, and its protection did not shield personal information against security breaches; (2) such deficiencies heightened the Company's exposure to a cyber-attack; and (3) as a result, Capital One's public statements were materially false and misleading at all relevant times.

Quad/Graphics, Inc. (NYSE:QUAD)

QUAD Lawsuit on behalf of: investors who purchased February 21, 2018 – October 29, 2019
Lead Plaintiff Deadline: January 6, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/quad-graphics-inc-loss-form?prid=4648&wire=1

According to the filed complaint, during the class period, Quad/Graphics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's book business in United States was underperforming; (2) as a result, the Company was likely to divest its book business; (3) the Company was unreasonably vulnerable to decreases in market prices; (4) to remain financially flexible while market prices decreased, the Company was likely to cut its quarterly dividend and expand its cost reduction programs; and (5) as a result of the foregoing, positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Resideo Technologies, Inc. (NYSE:REZI)

REZI Lawsuit on behalf of: investors who purchased October 29, 2018 – October 22, 2019
Lead Plaintiff Deadline: January 7, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/resideo-technologies-inc-loss-form?prid=4648&wire=1

According to the filed complaint, during the class period, Resideo Technologies, Inc. made materially false and/or misleading statements and/or failed to disclose that: (a) the negative operational effects of the Company's spin-off from Honeywell International Inc. were more substantial and persistent than disclosed and had negatively affected Resideo's product sales, supply chain, and gross margins, putting the Company's FY19 financial forecasts at risk; and (b) as a result of the foregoing, the Company's financial guidance lacked a reasonable basis and the Company was not on track to make its FY19 guidance as claimed.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 568510

NEW YORK, NY / ACCESSWIRE / November 29, 2019 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

Wright Medical Group N.V. (NASDAQ:WMGI) related to its purchase agreement with Stryker Corporation. Under the terms of the transaction, Wright Medical Group shareholders will have the right to receive $30.75 in cash for each Wright Medical Group shares owned. Click here for more information: https://www.monteverdelaw.com/case/wright-medical-group-nv. It is free and there is no cost or obligation to you.
Anixter International Inc (NYSE:AXE) related to its sale to CD&R Arrow Parent, LLC. Under the terms of the Transaction, Anixter Stockholders will have the right to receive $81.00 in cash for each Anixter common stock owned. Click here for more information: https://www.monteverdelaw.com/case/anixter-international-inc. It is free and there is no cost or obligation to you.
Cision Ltd (NYSE:CISN) related to its sale to MJ23 UK Acquisition Limited. Under the terms of the Merger Agreement, each share of CISN will automatically be exchanged for the right to receive $10.00 in cash per CISN share owned. Click here for more information: https://www.monteverdelaw.com/case/cision-ltd. It is free and there is no cost or obligation to you.
 

Monteverde & Associates PC is a national class action securities and consumer litigation law firm that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019 an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer.

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:

Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2019 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC

ReleaseID: 568507

NEW YORK, NY / ACCESSWIRE / November 29, 2019 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

Liberty Property Trust (NYSE:LPT)

The investigation concerns whether Liberty and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Liberty to Prologis, Inc. for 0.675x of a Prologis share for each Liberty share. If you are a Liberty shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/liberty-property-trust-lpt-prologis-stock-merger/.

Cision Ltd. (NYSE:CISN)

The investigation concerns whether Cision and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Cision to an affiliate of Platinum Equity for $10.00 per share. If you are a Cision shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/cision-ltd-cisn-stock-merger-platinum-equity/.

Innophos Holdings, Inc. (NASDAQ:IPHS)

The investigation concerns whether Innophos and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Innophos to an affiliate of One Rock Capital Partners, LLC for $32.00 per share. If you are an Innophos shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/innophos-holdings-inc-iphs-stock-merger-one-rock/.

On behalf of shareholders of these companies, Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP

ReleaseID: 568486

NEW YORK, NY / ACCESSWIRE / November 29, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Twitter, Inc. (NYSE:TWTR)

Investors Affected : August 6, 2019 – October 23, 2019

A class action has commenced on behalf of certain shareholders in Twitter, Inc. The filed complaint alleges that defendants engaged in a scheme to deceive the market and a course of conduct that artificially inflated Twitter's common share price and operated as a fraud or deceit on purchasers of Twitter common stock by misrepresenting the Company's operating condition and future business prospects. The scheme was perpetrated by making positive statements about Twitter's business while defendants knew, or disregarded with deliberate recklessness, certain adverse facts. When defendants' prior misrepresentations were disclosed and became apparent to the market, the price of Twitter's common stock fell precipitously.

Shareholders may find more information at https://securitiesclasslaw.com/securities/twitter-inc-loss-submission-form-2/?id=4656&from=1

Grubhub Inc. (NYSE:GRUB)

Investors Affected : July 30, 2019 – October 28, 2019

A class action has commenced on behalf of certain shareholders in Grubhub Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) customer orders were actually declining, despite the massive investments that the Company had made to spur demand for and use of its platform; (ii) Grubhub's new customer additions were generating significantly lower revenues as compared to historic cohorts because these customers were more prone to using competitor platforms; (iii) Grubhub's vaunted business model under which it secured exclusive partnerships had failed, and Grubhub needed to engage in the same aggressive nonpartnered sales tactics embraced by its competitors to generate significant revenue growth; (iv) Grubhub was required to spend substantial additional capital in order to grow revenues and retain market share in the face of heightened competitive dynamics and market saturation, eviscerating the Company's profitability; and (v) Grubhub was tracking tens of millions of dollars below its revenue and earnings guidance and such guidance lacked any reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/grubhub-inc-loss-submission-form/?id=4656&from=1

HEXO Corp. (NYSE:HEXO)

Investors Affected : January 25, 2019 – November 15, 2019

A class action has commenced on behalf of certain shareholders in HEXO Corp. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) HEXO's reported inventory was misstated as the Company was failing to write down or write off obsolete product that no longer had value; (2) HEXO was engaging in channel-stuffing in order to inflate its revenue figures and meet or exceed revenue guidance provided to investors; (3) HEXO was cultivating cannabis at its facility in Niagara, Ontario that was not appropriately licensed by Health Canada; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/hexo-corp-loss-submission-form/?id=4656&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 568518

NEW YORK, NY / ACCESSWIRE / November 29, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Altria Group, Inc. (NYSE:MO)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/altria-group-inc-loss-submission-form?prid=4655&wire=1
Lead Plaintiff Deadline: December 2, 2019
Class Period: December 20, 2018 to September 24, 2019

Allegations against MO include that: (i) Altria had conducted insufficient due diligence into JUUL prior to the Company's $12.8 billion investment, or 35% stake, in JUUL; (ii) Altria consequently failed to inform investors, or account for, material risks associated with JUUL's products and marketing practices, and the true value of JUUL and its products; (iii) all of the foregoing, as well as mounting public scrutiny, negative publicity, and governmental pressure on e-vapor products and JUUL made it reasonably likely that Altria's investment in JUUL would have a material negative impact on the Company's reputation and operations; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Match Group, Inc. (NASDAQ:MTCH)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/match-group-inc-loss-submission-form?prid=4655&wire=1
Lead Plaintiff Deadline: December 2, 2019
Class Period: August 6, 2019 to September 25, 2019

Allegations against MTCH include that: (1) the Company used fake love interest ads to convince customers to buy and upgrade subscriptions; (2) the Company made it difficult and confusing for consumers to cancel their subscriptions; (3) as a result, the Company was reasonably likely to be subject to regulatory scrutiny; (4) the Company lacked adequate disclosure controls and procedures; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Plantronics, Inc. (NYSE:PLT)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/plantronics-inc-loss-submission-form?prid=4655&wire=1
Lead Plaintiff Deadline: January 13, 2020
Class Period: July 2, 2018 to November 5, 2019

Allegations against PLT include that: (1) the Company had engaged in channel stuffing to artificially boost sales; (2) the Company's internal control over inventory levels was not effective; (3) the Company had not adequately monitored inventory levels ahead of multiple product launches, where the new models would displace demand for aging products; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 568517

NEW YORK, NY / ACCESSWIRE / November 29, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

Uber Technologies, Inc. (NYSE:UBER)

UBER Lawsuit on behalf of: investors who purchased on behalf of all persons and entities other than Defendants who purchased or otherwise acquired Uber securities pursuant and/or traceable to Uber's registration statement issued in connection with Uber's May 10, 2019 initial public stock offering.
Lead Plaintiff Deadline : December 3, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/uber-technologies-inc-loss-form?prid=4647&wire=1

According to the filed complaint, (1) at the time of the initial public offering, Uber was rapidly increasing subsidies for customer's rides and meals in a bid for market share, which caused the Company's sales and marketing expenses to swell; and (2) Defendants were cutting (or planned to cut) costs in key areas that undermined the Company's central growth opportunities.

Ruhnn Holding Limited (NASDAQ:RUHN)

RUHN Lawsuit on behalf of: investors who purchased all persons or entities who purchased Ruhnn American Depositary Shares pursuant and/or traceable to the Company's April 3, 2019 initial public offering.
Lead Plaintiff Deadline : December 6, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/ruhnn-holding-limited-loss-form?prid=4647&wire=1

According to the filed complaint, (1) at the time of the initial public offering ("IPO"), the number of Ruhnn's online stores had declined by nearly 40%; (2) at the time of the IPO, the number of Ruhnn's full-service Key Opinion Leaders had declined by nearly 44%; (3) as a result, the Company's net revenues derived from its full-service segment had declined by 46% on a sequential basis; and (3) as a result, defendants' statements about Ruhnn's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Armstrong Flooring, Inc. (NYSE:AFI)

AFI Lawsuit on behalf of: investors who purchased March 6, 2018 – November 4, 2019
Lead Plaintiff Deadline : January 14, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/armstrong-flooring-inc-loss-form?prid=4647&wire=1

According to the filed complaint, during the class period, Armstrong Flooring, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company had engaged in channel stuffing to artificially boost sales; (2) the Company's internal control over inventory levels was not effective; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 568509

NEW YORK, NY / ACCESSWIRE / November 29, 2019 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

Carolina Financial Corporation (NASDAQ:CARO) related to its sale to United Bankshares, Inc. Under the terms of the Merger, each share of Carolina Financial common stock will be converted into the right to receive 1.13 shares of United Common stock. Click here for more information: https://www.monteverdelaw.com/case/carolina-financial-corporation. It is free and there is no cost or obligation to you.
Aircastle Limited (NYSE:AYR) related to its sale to Marubeni Corporation. Under the terms of the transaction, Aircastle shareholders will receive $32.00 in cash for each Aircastle common stock owned. Click here for more information: https://www.monteverdelaw.com/case/aircastle-limited. It is free and there is no cost or obligation to you
William Lyon Homes (NYSE:WLH) related to its sale to Taylor Morrison Home Corporation. Under the terms of the agreement, Shareholders of William Lyon Homes have the right to receive $2.50 in cash for each William Lyon Homes common stock owned. Click here for more information: https://www.monteverdelaw.com/case/william-lyon-homes. It is free and there is no cost or obligation to you.
 

Monteverde & Associates PC is a national class action securities and consumer litigation law firm that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019 an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer.

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:

Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2019 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC

ReleaseID: 568508

BEDFORD, NS / ACCESSWIRE / November 29, 2019 / Silver Spruce Resources Inc. (TSXV:SSE)(FSE:S6Q1) ("Silver Spruce" or the "Company") has concluded its due diligence and will not negotiate a Definitive Purchase Agreement to acquire the Cocula project ("Cocula") in Jalisco State, Mexico.

Subject to its binding Letter of Agreement ("LOA") with ProDeMin, SA de CV ("ProDeMin") signed on July 13, 2019 and amended on September 10, 2019 ("Amendment"), Silver Spruce provided written notification on November 28, 2019 to ProDeMin to terminate the LOA and Amendment to acquire Cocula.

As per the Amendment, such written notice may be provided at any time prior to midnight ET, November 30, 2019, without further recourse or liability, and with no further obligation to assume the Contract.

About Silver Spruce Resources Inc.

Silver Spruce Resources Inc. is a Canadian junior exploration company which has signed a Definitive Agreement to acquire 100% of the Melchett Lake Zn-Au-Ag project in northern Ontario and is pursuing development of the Pino De Plata Ag project in western Chihuahua State, Mexico. Silver Spruce Resources Inc. continues to investigate opportunities that Management has identified or that have been presented to the Company for consideration.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. The company seeks Safe Harbour.

Contact:

Silver Spruce Resources Inc.
Karl Boltz, President/CEO/Director
(866) 641-3397
info@silverspruceresources.com
www.silverspruceresources.com

SOURCE: Silver Spruce Resources Inc.

ReleaseID: 568504

CALGARY, AB AND HERZLIYA, ISRAEL / ACCESSWIRE / November 29, 2019 / InnoCan Pharma Corporation (CSE:INNO) ("InnoCan" or the "Company") is pleased to provide its financial and operating results for the third quarter and nine months ended September 30, 2019, as well as providing an update of its business activities.

Business Update

"Our recent successful IPO in September 2019 and strong balance sheet, coupled with our highly experienced management team, have positioned InnoCan to execute upon its goals and business plan for "We have moved to the next phase of the Company's development with the recent signing of supply contracts (see press releases of September 5th and 18th, 2019) for manufacturing, filling and packaging of InnoCan's CBD OTC ("over the counter") topical and cosmetic products in accordance with InnoCan's formulations and specifications. We have now achieved the milestone of preparing for retail commercialization of InnoCan products in 2020. Furthermore, InnoCan expects to soon comments significant distribution agreements, which together with the supply agreements will enable InnoCan to enter CBD cosmetic and OTC topical markets and position InnoCan to succeed in the rapidly growing global consumer market for CBD enhanced products," added Ms. Bincovich, InnoCan's CEO.

Financial results for the nine month periods ended September 30, 2019 and 2018 and three month periods ended September 30, 2018 are as follows:

Nine months period ended

September 30,

Three months period ended

September 30,

 
2019
 
 
2018
 
 
2019
 
 
2018
 

 
USD in thousands
 
 
USD in thousands
 

Sales and marketing expense

 
 
401
 
 
 
110
 
 
 
215
 
 
 
44
 

Research and development expense

 
 
254
 
 
 
62
 
 
 
113
 
 
 
19
 

General and administrative expense

 
 
1,492
 
 
 
339
 
 
 
1,193
 
 
 
211
 

Operating loss

 
 
2,147
 
 
 
511
 
 
 
1,521
 
 
 
274
 

Finance (income)

 
 
 
 
 
 
(7
)
 
 
 
 
 
 
(7
)

Finance expense

 
 
2,099
 
 
 
19
 
 
 
2,097
 
 
 
17
 

Finance expense, net

 
 
2,099
 
 
 
12
 
 
 
2,097
 
 
 
10
 

Loss before taxes on income

 
 
4,246
 
 
 
523
 
 
 
3,618
 
 
 
284
 

Taxes on income

 
 
–
 
 
 
–
 
 
 
–
 
 
 
–
 

Total comprehensive loss

 
 
4,246
 
 
 
523
 
 
 
3,618
 
 
 
284
 

As of September 30, 2019

(USD in thousands)

As of December 31, 2018

(USD in thousands)

Total current assets

 
 
2,918
 
 
 
657
 

Total non-current assets

 
 
100
 
 
 
3
 

Total current liabilities

 
 
2,905
 
 
 
533
 

Total non-current liabilities

 
 
44
 
 
 
–
 

Working capital

 
 
13
 
 
 
124
 

Our complete third quarter financial operating results and Management Discussion and Analysis for the nine months period ended September 30, 2019 can be found at www.sedar.com.

About InnoCan Pharma Corporation

InnoCan brings pharmacological application to the burgeoning CBD marketplace. The founders and officers of the Company all have commercially successful track records in the pharmaceutical and technology sectors in Israel and global marketplace. InnoCan's business has three distinct operating segments relating to the incorporation in CBD products in their formulation: (i) research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products, (ii) research and development of non-pharmaceutical products for third parties in exchange for fees and/or royalties, and (iii) research and development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales. http://innocanpharma.com/

FORWARD-LOOKING AND INFORMATION CAUTIONARY STATEMENT

Certain information set forth in this news release, including, without limitation, information regarding the markets, requisite regulatory approvals and the anticipated timing for market entry, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond InnoCan's control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by InnoCan, including expectations and assumptions concerning the anticipated benefits of the product markets, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion and execution of requisite production and distribution arrangements. Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, distributors, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, market demand, or the need for additional time to conclude and/or satisfy distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact InnoCan can also be found in InnoCan's public reports and filings which are available under InnoCan's profile at www.sedar.com. Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. InnoCan does not undertake to update, correct or revise any forward-looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE

For further information, please contact:

For InnoCan Pharma Corporation:

Iris Bincovich, CEO
+972-54-3012842
info@innocanpharma.com

For Investor Relations:

Proconsul Capital Ltd.
Andreas Curkovic
416-577-9927

SOURCE: InnoCan Pharma Corporation

ReleaseID: 568501